PALO ALTO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)TO PROVIDE ADVOCACY DEDICATED TO PROMOTING LIFESAVING STEM CELL RESEARCH AND THERAPY DEVELOPMENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Expenses | N/A | N/A | N/A |
| Net Income | N/A | $0 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT N KLEIN II | CHAIRMAN OF THE BOARD | 0.02 |
Officer
Director
|
$0 | $0 | $0 |
| DON REED | SECRETARY/TREASURER | 0.77 |
Officer
Director
|
$0 | $0 | $0 |
| BERNARD SIEGEL | BOARD MEMBER | 0.01 |
Director
|
$0 | $0 | $0 |
| ROBERT N KLEIN III | BOARD MEMBER | 0.05 |
Director
|
$0 | $0 | $0 |
| ALYSSA G KLEIN | BOARD MEMBER | 0.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | No data | No data | $255 | No data |
| 2022 | No data | No data | $255 | No data |
| 2021 | $1,172,211 | $132,861 | $255 | $1,039,350 |
| 2020 | No data | $10 | $255 | No data |
| 2019 | $500,000 | $500,000 | $265 | No data |
Compare AMERICANS FOR STEM CELL THERAPIES AND CURES with other nonprofits in California and across the country.